#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4428	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2494	355.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1686	1686	C	564	C,A	376,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8164	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3908	410.0	0	.	n	.	0	T695C	SNP	695	695	T	1369	1369	C	589	C	383	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8164	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3908	410.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	2011	2011	A	474	A,T	318,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8164	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3908	410.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2645	2645	C	453	C	294	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8164	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3908	410.0	0	.	n	.	0	C2403T	SNP	2403	2403	C	3077	3077	T	436	T,C	228,71	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8164	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3908	410.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2719	2719	A	499	A	324	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8164	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3908	410.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3271	3271	C	487	C,T	333,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	374	folP	855	855	100.0	folP.l15.c4.ctg.1	1668	45.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1136	1138	AGC	52;52;51	A;G;C	39;39;38	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	936	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	54.3	1	SNP	p	S91F	1	.	.	271	273	TTC	717	719	TTC	74;74;74	T;T;C,A	51;50;50,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	936	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	54.3	1	SNP	p	D95G	1	.	.	283	285	GGC	729	731	GGC	75;75;75	G;G;C	52;51;50	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	936	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	54.3	1	SNP	p	G95N	0	.	.	283	285	GGC	729	731	GGC	75;75;75	G;G;C	52;51;50	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	300	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1439	43.3	1	SNP	p	G45D	0	.	.	133	135	GGC	597	599	GGC	73;74;74	G;G;C	48;49;50	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	210	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1052	38.7	0	.	n	.	0	A197.	DEL	197	197	A	639	639	A	80	A	54	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	758	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3100	49.3	1	SNP	p	D86N	0	.	.	256	258	GAC	468	470	GAC	81;81;83	G,C;A;C,A	53,1;48;54,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	758	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3100	49.3	1	SNP	p	S87R	1	.	.	259	261	CGT	471	473	CGT	83;83;85	C;G,T;T	56;53,1;55	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	758	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3100	49.3	1	SNP	p	R87W	0	.	.	259	261	CGT	471	473	CGT	83;83;85	C;G,T;T	56;53,1;55	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	758	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3100	49.3	1	SNP	p	R87I	0	.	.	259	261	CGT	471	473	CGT	83;83;85	C;G,T;T	56;53,1;55	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	758	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3100	49.3	1	SNP	p	S88P	0	.	.	262	264	TCC	474	476	TCC	85;85;85	T;C,T;C	56;56,1;55	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	644	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2909	45.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1733	1735	GGC	44;44;44	G;G;C	34;32;31	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	796	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2260	69.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1253	1255	GCA	96;99;101	G;C;A,C	62;65;65,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	796	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2260	69.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1256	1258	ATC	105;106;105	A;T;C	69;70;68	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	796	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2260	69.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1268	1270	GTG	108;108;108	G,C;T,G;G,T	70,1;70,1;70,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	796	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2260	69.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1268	1270	GTG	108;108;108	G,C;T,G;G,T	70,1;70,1;70,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	796	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2260	69.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1772	1774	ACC	58;59;57	A;C;C	38;43;43	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	796	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2260	69.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1826	1828	GCG	56;57;58	G;C;G	38;36;33	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	796	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2260	69.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1826	1828	GCG	56;57;58	G;C;G	38;36;33	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	796	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2260	69.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1949	1951	AGC	64;66;69	A;G;C,T	47;48;49,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	796	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2260	69.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1958	1960	GGC	58;58;59	G;G;C	40;40;39	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	796	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2260	69.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1976	1978	CCG	62;62;62	C;C;G	41;41;43	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1402	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	3135	83.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1544	1546	CCG	52;52;54	C,G;C;G	37,2;39;34	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	424	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1861	44.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	648	648	C	44	C	28	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	I45V	NONSYN	133	135	ATT	537	539	GTT	58;56;56	G;T;T	40;38;38	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	N121S	NONSYN	361	363	AAC	765	767	AGC	21;21;20	A;G;C	16;16;16	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	768	770	AAA	20;20;20	A;A;A	16;16;16	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	795	797	TAT	21;22;22	T;A;T	17;17;17	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	N134E	NONSYN	400	402	AAT	804	806	GAG	20;22;22	G;A;G	15;17;16	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	V135L	NONSYN	403	405	GTG	807	809	CTT	23;23;23	C;T;T	17;17;18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	G140K	NONSYN	418	420	GGA	822	824	AAA	23;23;23	A;A;A	18;18;18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	831	833	GAA	23;27;29	G;A;A	18;19;21	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	855	857	GCA	35;35;35	G;C;A	25;25;24	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	A196V	NONSYN	586	588	GCC	990	992	GTC	49;49;49	G;T;C	34;34;34	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	K207_M208insK	INS	619	619	A	1023	1023	A	60	A,T	37,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1041	1043	TCA	69;69;69	T;C;A	43;43;43	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	362	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1734	40.9	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1158	1158	T	60	T	41	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2014	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4898	80.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	172	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1165	32.5	1	SNP	p	V57M	1	.	.	169	171	ATG	477	479	ATG	70;70;70	A;T;G	49;49;49	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
